Pierce Protease Inhibitor Tablets, EDTA
Ended Purchase order Nebraska Awarded
- Contract number
- 4800159810
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Nebraska
- Contract amount
- $340.65
Award facts
- Completion date
Award details come from statecontracts.nebraska.gov. Updated .
About this award
The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has awarded a purchase order (PO) contract to Life Technologies Corporation of Pittsburgh, Pennsylvania, for the procurement of scientific laboratory supplies. Specifically, the contract involves the acquisition of one unit of Pierce Protease Inhibitor Tablets, EDTA, with a material number A32965, priced at $340.65.
The contract, identified as 4800159810, was executed on November 19, 2025, with a scheduled completion date of November 26, 2025. The purchase order includes standard terms of Net 30 payment, F.O.B. destination delivery to UNMC Shipping and Receiving at DRC 1027, and is governed by the University of Nebraska's standard purchase terms. The total contract value is $340.65, and the purchasing authority is acting on behalf of the Board of Regents of the University of Nebraska, with the transaction maintaining a tax-exempt status.
Line items
| Item | Total |
|---|---|
| Pierce Protease Inhibitor Tablets, EDTA | $340.65 |
Files
| File | Type | Posted |
|---|---|---|
| 4800159810.pdf |
Quick answers
Who was awarded contract 4800159810?
Contract 4800159810 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Nebraska on November 19, 2025.
How much is contract 4800159810 worth?
Its contract amount is $340.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award